JOHNSON KENNETH ERLAND (CIK 1743774) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-03). Recent activity: Sell XERS (15,476 shares), Sell XERS (25,842 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-03 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 15,476 | $55,095 |
| 2025-02-03 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 25,842 | $91,998 |
Source: SEC Form 4 filings · as of 2025-02-03